Neurocrine Biosciences to Present at Bear Stearns 17th Annual Healthcare Conference
Presentation Will be Webcast Today at 11:00am EDT
SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at Bear Stearns 17th Annual Healthcare Conference in New York today, Monday, September 13, 2004 at 11:00am EDT/8:00am PDT. The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com.
Gary Lyons, President and Chief Executive Officer of Neurocrine will report on indiplon, the Company's late stage clinical development program for the treatment of insomnia, highlighting results from the Company's recent Phase III modified release (15 mg) clinical study in elderly patients with chronic insomnia.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or Elizabeth Foster. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will become available approximately one hour after the live webcast concludes and will be archived until Monday, September 27, 2004.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, certain female and male disorders, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.